Angelini Pharma S.p.A. announced it will acquire Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) for $31.50 per share in cash, totaling approximately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE